Aprea Therapeutics Inc
APRE1.700USD
+0.040+2.41%
종가 08/04, 16:00（ET）시세는 15분 지연됩니다
1.680USD+1.680장외 거래 08/04, 20:00 (ET)
9.37M시가총액
손실P/E TTM
분기별
분기별+연간
분기별
연간
YOY
빈 행 숨기기
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
총 수익
-57.31%162.46K
1362.29%205.82K
11.00%354.62K
124.91%561.57K
--380.57K
--14.07K
--319.47K
--249.69K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
수익
-57.31%162.46K
1362.29%205.82K
11.00%354.62K
124.91%561.57K
--380.57K
--14.07K
--319.47K
--249.69K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
영업 비용
20.33%4.25M
-6.97%3.43M
15.86%4.45M
13.00%4.41M
-23.63%3.53M
39.12%3.69M
-8.52%3.84M
-82.62%3.90M
-42.75%4.62M
-66.13%2.65M
-55.46%4.20M
124.51%22.45M
-20.75%8.07M
-44.96%7.83M
-22.92%9.43M
-30.96%10.00M
-14.17%10.19M
18.73%14.22M
69.49%12.23M
143.85%14.48M
169.36%11.87M
144.52%11.98M
146.30%7.22M
--5.94M
--4.41M
--4.90M
--2.93M
연구개발비
55.16%2.48M
15.32%2.36M
34.10%2.85M
16.12%2.56M
27.36%1.60M
284.96%2.05M
89.93%2.12M
-67.66%2.20M
-69.27%1.26M
-88.09%531.41K
-81.42%1.12M
2.36%6.81M
-39.54%4.09M
-52.16%4.46M
-31.34%6.02M
-37.78%6.65M
-25.64%6.76M
15.99%9.33M
78.42%8.76M
147.56%10.69M
147.28%9.10M
82.98%8.04M
112.85%4.91M
--4.32M
--3.68M
--4.39M
--2.31M
감가상각 및 고갈비용
-11.82%5.43K
8.86%5.43K
279.12%5.43K
2267.86%5.30K
1401.71%6.16K
--4.99K
-97.67%1.43K
-99.65%224.00
-99.36%410.00
----
-11.63%61.37K
5.74%63.69K
-16.10%63.77K
15.99%65.99K
22.50%69.44K
24.83%60.24K
12.14%76.00K
9.72%56.89K
-8.28%56.69K
1757.43%48.26K
142.72%67.77K
2788.86%51.85K
2637.25%61.81K
--2.60K
--27.92K
--1.79K
--2.26K
영업 이익
-29.71%-4.09M
12.21%-3.23M
-16.30%-4.10M
-5.35%-3.85M
31.86%-3.15M
-38.59%-3.67M
16.13%-3.52M
83.73%-3.65M
42.75%-4.62M
66.13%-2.65M
55.46%-4.20M
-124.51%-22.45M
20.75%-8.07M
44.96%-7.83M
22.92%-9.43M
30.96%-10.00M
14.17%-10.19M
-18.73%-14.22M
-69.49%-12.23M
-143.85%-14.48M
-169.36%-11.87M
-144.52%-11.98M
-146.30%-7.22M
---5.94M
---4.41M
---4.90M
---2.93M
영업외 순이자수익(비용)
영업외 이자비용
-27.76%204.73K
-11.49%274.63K
8.57%348.74K
13.73%382.37K
10.53%283.40K
27.65%310.29K
112.55%321.21K
540.53%336.22K
12909.13%256.41K
--243.08K
--151.12K
--52.49K
--1.97K
----
----
----
----
-97.21%4.74K
----
--2.68K
--224.44K
8494300.00%169.89K
----
----
----
--2.00
--4.00
영업외 이자비용
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--33.00
--588.00
--1.06K
----
----
----
----
----
--6.10K
--4.09K
--3.35K
----
----
유가증권 매각이익
-192.22%-51.80K
172.02%56.62K
-1132.43%-35.49K
-109.76%-5.50K
507.16%56.18K
-133.99%-78.61K
-111.83%-2.88K
-63.53%56.36K
-110.13%-13.80K
-147.88%-33.60K
211.17%24.35K
161.13%154.57K
-73.91%136.21K
105.98%70.17K
70.62%-21.91K
86.62%-252.84K
-76.78%521.98K
7.05%-1.17M
-107.65%-74.56K
-377.87%-1.89M
140.18%2.25M
-674.81%-1.26M
569.80%975.03K
--680.06K
--935.92K
--219.70K
---207.54K
특별수익(비용)
----
----
----
----
----
--0.00
--0.00
100.00%0.00
----
--0.00
--0.00
---76.02M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
세전 소득
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
소득세
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
세후 소득
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
계속 영업 순이익
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
지배지분 귀속 순이익
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
보통주주 귀속 순이익
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
기본 주당순이익
1.98%-0.66
47.25%-0.49
25.75%-0.64
33.08%-0.58
50.17%-0.67
-0.34%-0.92
63.06%-0.86
98.99%-0.87
81.47%-1.34
87.25%-0.92
73.92%-2.32
-796.14%-86.72
20.59%-7.25
50.44%-7.20
23.43%-8.90
37.61%-9.68
-2.21%-9.13
-47.77%-14.53
-78.72%-11.63
-183.07%-15.51
-146.81%-8.93
-101.82%-9.83
-99.13%-6.51
---5.48
---3.62
---4.87
---3.27
희석 주당순이익
1.98%-0.66
47.25%-0.49
25.75%-0.64
33.08%-0.58
50.17%-0.67
-0.34%-0.92
63.06%-0.86
98.99%-0.87
81.47%-1.34
87.25%-0.92
73.92%-2.32
-796.14%-86.72
20.59%-7.25
50.44%-7.20
23.43%-8.90
37.61%-9.68
-2.21%-9.13
-47.77%-14.53
-78.72%-11.63
-183.07%-15.51
-146.81%-8.93
-101.82%-9.83
-99.13%-6.51
---5.48
---3.62
---4.87
---3.27
주당 배당금
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
통화 단위
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
감사 의견
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
